4 Undervalued Stocks Worth Investigating: Where I See Opportunity in Fresenius Medical Care, Bristol Myers Squibb, Watsco, and Devon Energy
Four companies, four different investment stories, and one question every value investor should ask: Am I buying a genuinely undervalued business, or am I simply buying something that has gotten cheaper for a very good reason? October 16, 2026 | Stock Analysis • Value Investing • Dividend Investing I've always believed that some of the best opportunities in the stock market emerge when investors become frustrated, impatient, or simply lose interest in otherwise respectable businesses. Wall Street has a remarkable ability to convince itself that a company experiencing temporary difficulties must be permanently damaged. Sometimes that pessimism is justified. Other times, it creates precisely the kind of valuation disconnect that patient investors should be looking for. The challenge is knowing the difference. As I examine the market in October 2026, I'm increasingly interested in companies that offer something more tangible than an exciting growth narrative. I want operating cash...